Quest Diagnostics

Quest Diagnostics Equity

The The Equity of Quest Diagnostics (DGX) as of Nov 19, 2026 is 7.17 B USD. In the previous year, The Equity was 6.78 B USD — a change of 5.78% (higher).

Equity

7.17 BUSD

YoY

5.78%

Last updated:

In 2025, Quest Diagnostics's equity was 7.17 B USD, a 5.78% increase from the 6.78 B USD equity in the previous year.

The Quest Diagnostics Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
5.22 B USD
Jan 1, 2019
5.64 B USD
Jan 1, 2020
6.76 B USD
Jan 1, 2021
6.44 B USD
Jan 1, 2022
5.89 B USD
Jan 1, 2023
6.31 B USD
Jan 1, 2024
6.78 B USD
Jan 1, 2025
7.17 B USD
The Quest Diagnostics Equity history
YEAREquityYoY
7.17 BUSD+5.78%
6.78 BUSD+7.47%
6.31 BUSD+7.03%
5.89 BUSD-8.55%
6.44 BUSD-4.66%
6.76 BUSD+19.82%
5.64 BUSD+8.15%
5.22 BUSD+5.99%
4.92 BUSD+6.33%
4.63 BUSD-1.20%
4.68 BUSD+8.90%
4.30 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quest Diagnostics Stock analysis

What does Quest Diagnostics do? Quest Diagnostics Inc is a leading company in the field of diagnostic information and services, headquartered in New Jersey, USA. The company is dedicated to providing medical professionals and patients worldwide with fast, accurate, and preventive diagnostic tests. The history of Quest Diagnostics dates back to 1967 when the company MetPath was founded by Dr. Paul A. Brown. In the following years, several acquisitions and mergers took place, eventually leading to the establishment of Quest Diagnostics in 1996. Since then, the company has continuously evolved and now offers a wide range of diagnostic tests and services, ranging from the analysis of blood samples to genetic testing procedures. The business model of Quest Diagnostics is based on providing high-quality and individualized information to medical professionals and patients to assist in the diagnosis, treatment, and cure of their health problems. The company works closely with doctors, hospitals, and other medical institutions worldwide to offer a comprehensive range of innovative diagnostic products, procedures, and technologies tailored to meet specific needs. Quest Diagnostics offers a wide range of services, ranging from laboratory testing to data management and clinical trials. The company has various business segments, including the Diagnostic Services business, the Medical Research Services business, and the Information Services business. In the field of Diagnostic Services, Quest Diagnostics offers a broad spectrum of laboratory tests divided into different categories such as cancer diagnostics, cardiology, endocrinology, immunology, and infectious diseases. The company also provides a variety of genetic tests that enable precise analysis of individual genomes, supporting the diagnosis and treatment of various genetic disorders. In the medical research field, Quest Diagnostics provides a range of services to support clinical trials and drug development. The company also offers a wide range of laboratory tests used in biomedical research to improve people's health and well-being. The Information Services business segment of Quest Diagnostics mainly focuses on providing innovative solutions in the field of data management and information technology. This includes the development of software tools that can be used for the analysis and management of health data. Additionally, the company offers consulting services to help medical professionals address challenges related to information processing and data integration. Quest Diagnostics is a company based on innovation and knowledge that collaborates closely with doctors, clinics, and other medical facilities worldwide to offer a relatively comprehensive range of need-specific diagnostic products, procedures, and solutions. From cancer diagnostics to genomic diagnostics, from clinical trials to information and data services, and a wide range of molecular diagnostic tests and laboratory analyses, Quest Diagnostics provides top-notch solutions for optimal patient care, contributing to the goal of improving global healthcare for people worldwide. Quest Diagnostics is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Quest Diagnostics's Equity

Quest Diagnostics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Quest Diagnostics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Quest Diagnostics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Quest Diagnostics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Quest Diagnostics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Quest Diagnostics stock

The Equity of Quest Diagnostics is 7.17 B USD in 2025.

The Equity of Quest Diagnostics changed from 6.78 B USD to 7.17 B USD, representing a 5.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Quest Diagnostics since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Quest Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Quest Diagnostics

All Key Metrics — Quest Diagnostics